A metabonomic evaluation of the monocrotaline-induced sinusoidal obstruction syndrome (SOS) in rats

Toxicology and Applied Pharmacology

Volumn 276, Issue 2, 2014, Pages 147-156

  Conotte, R ^a   Colet, J M ^a  

^a UNIVERSITY OF MONS   (Belgium)

Author keywords

Hepatotoxicity; Metabonomic; Monocrotaline; Multivariate data analysis; Sinusoidal obstruction syndrome

Indexed keywords

ASPARTATE AMINOTRANSFERASE; GLUTATHIONE; MONOCROTALINE; NITRIC OXIDE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOMICS; CANCER DIAGNOSIS; CELL PROTECTION; COMPARATIVE STUDY; CONTROLLED STUDY; EARLY DIAGNOSIS; EVALUATION STUDY; LIVER NECROSIS; LIVER TOXICITY; LIVER VENOOCCLUSIVE DISEASE; MALE; METABONOMIC EVALUATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTIAL LEAST SQUARE DISCRIMINANT ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; UREA CYCLE; URINALYSIS;

(1)H-NMR; HEPATOTOXICITY; METABONOMIC; MONOCROTALINE; MULTIVARIATE DATA ANALYSIS; SINUSOIDAL OBSTRUCTION SYNDROME;

ANIMALS; ENERGY METABOLISM; GLUTATHIONE; HEPATIC VENO-OCCLUSIVE DISEASE; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOMICS; MONOCROTALINE; NECROSIS; NITRIC OXIDE; RATS; RATS, WISTAR;

EID: 84897381050     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2014.02.008     Document Type: Article

References (37)

1. Bando K., Kunimatsu T., Sakai J., Kimura J., Funabashi H. GC-MS-based metabolomics reveals mechanism of action for hydrazine induced hepatotoxicity in rats. J. Appl. Toxicol. 2011, 31:524-535. (http://www.ncbi.nlm.nih.gov/pubmed/1154879).
2. Beckonert O., Keun H.C., Ebbels T.M., Bundy J., Holmes E., et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protoc. 2007, 2(11):2692-2703. (http://www.ncbi.nlm.nih.gov/pubmed/18007604).
3. Brouquet A., Andreou A., Vauthey J.N. The management of solitary colorectal liver metastases. Surgeon 2011, 9(5):265-272. (http://www.ncbi.nlm.nih.gov/pubmed/21843821).
4. Chen Z., Huo J.R. Hepatic veno-occlusive disease associated with toxicity of pyrrolizidine alkaloids in herbal preparations. Neth. J. Med. 2010, 68(6):252-260. (http://www.ncbi.nlm.nih.gov/pubmed/20558855).
5. Chojkier M. Hepatic sinusoidal-obstruction syndrome: toxicity of pyrrolizidine alkaloids. J. Hepatol. 2003, 39(3):437-446. (http://www.ncbi.nlm.nih.gov/pubmed/12927933).
6. Copple B.L., Banes A., Ganey P.E., Roth R.A. Endothelial cell injury and fibrin deposition in rat liver after monocrotaline exposure. Toxicol. Sci. 2002, 65(2):309-318. (http://www.ncbi.nlm.nih.gov/pubmed/11812935).
7. DeLeve L.D., Shulman H.M., McDonald G.B. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin. Liver Dis. 2002, 22(1):27-42. (http://www.ncbi.nlm.nih.gov/pubmed/11928077).
8. DeLeve L.D., Wang X., Kanel G.C., Ito Y., Bethea N.W., et al. Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome. Hepatology 2003, 38(4):900-908. (http://www.ncbi.nlm.nih.gov/pubmed/14512877).
9. Gamble J.G., Lehninger A.L. Transport of ornithine and citrulline across the mitochondrial membrane. J. Biol. Chem. 1973, 248(2):610-618. (http://www.ncbi.nlm.nih.gov/pubmed/4684694).
10. Hasim A., Ali M., Mamtimin B., Ma J.Q., Li Q.Z., et al. Metabonomic signature analysis of cervical carcinoma and precancerous lesions in women by (1)H NMR spectroscopy. Exp. Ther. Med. 2012, 3(6):945-951. (http://www.ncbi.nlm.nih.gov/pubmed/22969997).
11. Helmy A. Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome. Aliment. Pharmacol. Ther. 2006, 23(1):11-25. (11-25. http://www.ncbi.nlm.nih.gov/pubmed/16393276).
12. Kawada K., Hasegawa S., Murakami T., Itatani Y., Hosogi H., et al. Molecular mechanisms of liver metastasis. Int. J. Clin. Oncol. 2011, 16(5):464-472. (http://www.ncbi.nlm.nih.gov/pubmed/21847533).
13. Konopke R., Roth J., Volk A., Pistorius S., Folprecht G., et al. Colorectal liver metastases: an update on palliative treatment options. J. Gastrointest. Liver Dis. 2012, 21(1):83-91. (http://www.ncbi.nlm.nih.gov/pubmed/22457864).
14. Kumar S., DeLeve L.D., Kamath P.S., Tefferi A. Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation. Mayo Clin. Proc. 2003, 78(5):589-598. (http://www.ncbi.nlm.nih.gov/pubmed/12744547).
15. Kumar B.S., Chung B.C., Kwon O.S., Jung B.H. Discovery of common urinary biomarkers for hepatotoxicity induced by carbon tetrachloride, acetaminophen and methotrexate by mass spectrometry-based metabolomics. J. Appl. Toxicol. 2012, 32(7):505-520. (http://www.ncbi.nlm.nih.gov/pubmed/22131085).
16. Lindon J.C., Nicholson J.K. Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics. Annu. Rev. Anal. Chem. 2008, 1:45-69. (http://www.ncbi.nlm.nih.gov/pubmed/20636074).
17. Lindon J.C., Holmes E., Nicholson J.K. Metabonomics techniques and applications to pharmaceutical research & development. Pharm. Res. 2006, 23(6):1075-1088. (http://www.ncbi.nlm.nih.gov/pubmed/16715371).
18. Liu Y., Huang R., Liu L., Peng J., Xiao B., et al. Metabonomics study of urine from Sprague-Dawley rats exposed to Huang-yao-zi using (1)H NMR spectroscopy. J. Pharm. Biomed. Anal. 2010, 52(1):136-141. (http://www.ncbi.nlm.nih.gov/pubmed/20061116).
19. Lu C., Wang Y., Sheng Z., Liu G., Fu Z., et al. NMR-based metabonomic analysis of the hepatotoxicity induced by combined exposure to PCBs and TCDD in rats. Toxicol. Appl. Pharmacol. 2010, 248(3):178-184.
20. Nelson H., Petrelli N., Carlin A., Couture J., Fleshman J., et al. Guidelines 2000 for colon and rectal cancer surgery. J. Natl. Cancer Inst. 2001, (8):583-596. (http://www.ncbi.nlm.nih.gov/pubmed/11309435).
21. Nicholson J.K., Lindon J.C. Systems biology. Metabonomics Nat. 2008, 455(7216):1054-1056. (http://www.ncbi.nlm.nih.gov/pubmed/18948945).
22. Nicholson J.K., Connelly J., Lindon J.C., Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 2002, 1(2):153-161. (http://www.ncbi.nlm.nih.gov/pubmed/12120097).
23. Nordlinger B., Sorbye H., Glimelius B., Poston G.J., Schlag P.M., et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled 2008, 371(9617):1007-1016. (http://www.ncbi.nlm.nih.gov/pubmed/18358928.).
24. Robertson D.G. Metabonomics in toxicology: a review. Toxicol. Sci. 2005, 85(2):809-822. (http://www.ncbi.nlm.nih.gov/pubmed/15689416).
25. Rubbia-Brandt L., Audard V., Sartoretti P., Roth A.D., Brezault C., et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann. Oncol. 2004, (3):460-466. (http://www.ncbi.nlm.nih.gov/pubmed/14998849).
26. Schiffer E., Frossard J.L., Rubbia-Brandt L., Mentha G., Pastor C.M. Hepatic regeneration is decreased in a rat model of sinusoidal obstruction syndrome. J. Surg. Oncol. 2009, 99(7):439-446. (http://www.ncbi.nlm.nih.gov/pubmed/19353590).
27. Shockcor J.P., Holmes E. Metabonomic applications in toxicity screening and disease diagnosis. Curr. Top. Med. Chem. 2002, 2:35-51.
28. Tang B., Ding J., Wu F., Chen L., Yang Y., et al. 1H NMR-based metabonomics study of the urinary biochemical changes in Kansui treated rat. J. Ethnopharmacol. 2012, 141(1):134-142. (http://www.ncbi.nlm.nih.gov/pubmed/22406398).
29. Timbrell J.A., Waterfield C.J., Draper R.P. Use of urinary taurine and creatine as biomarkers of organ dysfunction and metabolic perturbations. Comp. Haematol. Int. 1995, 5(2):112-119.
30. Warskulat U., Zhang F., Häussinger D. Taurine is an osmolyte in rat liver macrophages (Kupffer cells). J. Hepatol. 1997, 26(6):1340-1347.
31. Weik C., Warskulat U., Bode J., Peters-Regehr T., Häussinger D. Compatible organic osmolytes in rat liver sinusoidal endothelial cells. Hepatology 1998, 27(2):569-575. (http://www.ncbi.nlm.nih.gov/pubmed/9462659).
32. Wettstein M., Weik C., Holneicher C., Häussinger D. Betaine as an osmolyte in rat liver: metabolism and cell-to-cell interactions. Hepatology 1998, 27(3):787-793. (http://www.ncbi.nlm.nih.gov/pubmed/9500708).
33. Wettstein M., Peters-Regehr T., Kubitz R., Fischer R., Holneicher C. Release of osmolytes induced by phagocytosis and hormones in rat liver. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 278(2):G227-G233. (http://www.ncbi.nlm.nih.gov/pubmed/10666046).
34. Yamashita H., Itsuki A., Kimoto M., Hiemori M., Tsuji H. Acetate generation in rat liver mitochondria; acetyl-CoA hydrolase activity is demonstrated by 3-ketoacyl-CoA thiolase. Biochim. Biophys. Acta 2006, 1761(1):17-23. (http://www.ncbi.nlm.nih.gov/pubmed/16476568).
35. Yang Y.C., Crowder J., Wardle N.J., Yang L., White K.N., et al. 1H NMR study of monocrotaline and its metabolites in human blood. Food Chem. Toxicol. 2011, 49(11):2793-2799. (http://www.ncbi.nlm.nih.gov/pubmed/21843583).
36. Yee S.B., Hanumegowda U.M., Copple B.L., Shibuya M., Ganey P.E., et al. Endothelial cell injury and coagulation system activation during synergistic hepatotoxicity from monocrotaline and bacterial lipopolysaccharide coexposure. Toxicol. Sci. 2003, 74(1):203-214. (http://www.ncbi.nlm.nih.gov/pubmed/12730616).
37. Zhang L., Ye Y., An Y., Tian Y., Wang Y., et al. Systems responses of rats to aflatoxin B1 exposure revealed with metabonomic changes in multiple biological matrices. J. Proteome Res. 2011, 10(2):614-623. (http://www.ncbi.nlm.nih.gov/pubmed/21080729).